Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review (Q36162401)
Jump to navigation
Jump to search
scientific article
Sprache | Label | Description | Also known as |
---|---|---|---|
Englisch | Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review |
scientific article |
Statements
1 reference
Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review (English)
1 reference
George W Rutherford
1 reference
13 October 2016
14 references
23 March 2019
22 June 2019
25 June 2019
2 October 2019
19 October 2019
3 November 2019
26 April 2020
1 July 2020
18 December 2020
22 January 2021
26 January 2021
25 October 2022
10 January 2024
14 references
23 March 2019
22 June 2019
25 June 2019
2 October 2019
19 October 2019
3 November 2019
26 April 2020
1 July 2020
18 December 2020
22 January 2021
26 January 2021
25 October 2022
10 January 2024
e0162775
1 reference
2 references
25 October 2022
10 January 2024
1 reference
Identifiers
1 reference
1 reference
1 reference